When a clinical trial has no drug to ship, what becomes supply? Non-pharmacological trials still require sourcing, tracking, qualification, and control.
- AI In Clinical Supply: From Forecasting To Execution Decisions
- Accountability Gaps Can Break Clinical Supply Contracts
- When Clinical Supply Becomes A Clinical Decision
- How To Build Clinical Supply Into Drug Development From The Start
- When Communication Fails, Clinical Supply Risk Grows
- When IRT Configuration Decisions Disrupt Clinical Supply
- Fixing The Data Problem Before AI Can Help Clinical Trial Supply
- The Shipment Arrived. The Inventory Didn't: Understanding The Hidden Data Dependencies Behind Depot-To-Site Deliveries
ON-DEMAND WEBINARS
Achieving supply chain resilience is crucial, and flexible distribution strategies and ready-to-use depot and logistics networks are instrumental in establishing limitless flexibility and expertise capable of identifying possible risks.
Understand state pharmacy regulations, prescription requirements, and operational considerations for shipping clinical supplies directly from pharmacies to patients' homes in decentralized trial models.
Explore how demand-led, decentralized clinical supply models are reshaping complex trials by reducing waste, accelerating timelines, and advancing patient-centric access to investigational therapies.
Clinical supply innovators from across the industry share their experiences and lessons learned as they work to normalize the use of adherence measurement tools and smart medicine packages.
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![GettyImages-1744064144-pencil-hand-automation-gears-ai]( "Automation Testing In RTSM Software: What Is It And What's The Impact")
Automation Testing In RTSM Software: What Is It And What's The ImpactMove beyond the limitations of manual oversight to see how automated frameworks ensure precision, speed, and reliability for the most sophisticated and adaptive clinical trial designs.
-
![Scientist research laboratory pipette GettyImages-487041629]( "Overcoming The Complex Logistics Of Autologous Cell Therapy Trials: A Deep Dive Into Challenges And Solutions")
Overcoming The Complex Logistics Of Autologous Cell Therapy Trials: A Deep Dive Into Challenges And SolutionsExplore critical logistical requirements in autologous cell therapies logistics and learn how to overcome challenges and achieve successful and timely autologous cell therapy trials.
-
![West]( "Vial Containment Systems For Gene And Cell Therapies")
Vial Containment Systems For Gene And Cell TherapiesCZ vial-stopper-seal combinations offer a viable solution for the challenges associated with low-temperature storage of cell therapy drug products.
-
![GettyImages-1404941712-Capsules_Blister_Packaging]( "Advancing Your API To First Human Dose Trials More Efficiently")
Advancing Your API To First Human Dose Trials More EfficientlyLearn how end-to-end support for development and manufacturing, clinical trial services, advanced drug delivery, and commercial packaging can accelerate drug development and time to market.
-
![Supply Chain - Getty- 1159559071]( "European Clinical Supply Planning – Balancing Cost, Flexibility, And Time")
European Clinical Supply Planning – Balancing Cost, Flexibility, And TimeBy evaluating the key parameters of a study, sponsors can identify the most effective location for packaging and distributing clinical trial supplies.
-
![GettyImages-871431000 doctor partner]( "3 Reasons Sponsors Should Own The RTSM Vendor Relationship")
3 Reasons Sponsors Should Own The RTSM Vendor RelationshipExplore how direct management of study randomization and supply chains reduces communication delays, improves system design, and protects clinical data integrity from accidental unblinding.
-
![GettyImages-1445871463 supply chain]( "A Guide To RTSM For Clinical Trials")
A Guide To RTSM For Clinical TrialsLooking ahead, the evolution of RTSM in clinical trials points towards cloud-based solutions, heightened emphasis on patient safety, and greater collaboration among stakeholders. Learn how you can prepare.
-
![iStock-1088247762-risk]( "Avoiding The Risk Of A Non-Transparent Clinical Supply Solution")
Avoiding The Risk Of A Non-Transparent Clinical Supply SolutionWith the supply chain and transportation logistics disruption caused by the COVID-19 pandemic, full documentation and complete transparency becomes even more important to avoid delays and assert provenance.
-
![gettyimages-946264212-170667a]( "Navigate Complex Ancillary Supply Sourcing Challenges")
Navigate Complex Ancillary Supply Sourcing ChallengesExplore the evolvement of the clinical trial landscape over recent years, as well as the new challenges that this poses for the clinical supply chain.
-
![GettyImages-2167387195-computer-graphs-hand-team-digital]( "Outgrowing Excel: Implementing RTSM In A Live Phase I Trial")
Outgrowing Excel: Implementing RTSM In A Live Phase I TrialLearn how a clinical-stage oncology biotech successfully transitioned a live Phase I trial from manual spreadsheets to RTSM without disrupting site momentum or patient enrollment.
- Can Your Operating Model Grow? Preparing Clinical Supply For What Comes Next
- The Biggest Early-Stage Clinical Supply Mistake? Building Too Much, Too Soon.
- How Clinical Supply Is Shaping The Next Generation Of Cell And Gene Therapies
- First Advisors In: Meet Clinical Supply Leader's Inaugural Board Members
CATALENT CORNER
| Insights from Catalent's Clinical Supply Experts |
SPONSORED CONTENT
Impact Of Supplier Choice On APAC Clinical Trial Execution
Learn about strategies Asia-Pacific has become an increasingly complex and congested destination for clinical trials as local and global sponsors alike flock to the region to take advantage of its many benefits, including access to large patient pools. Choosing the right clinical packaging and supply chain partner to support these studies is critical and can vary significantly based upon what countries are involved and the types of services required.
